Where is OrganOx located?

OrganOx is headquartered in Oxford, United Kingdom. It is registered at The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT.

Who is the current CEO of OrganOx?

Craig Marshall of OrganOx. They are also an angel investors in 1 startup.

Which legal entities is OrganOx associated with?

OrganOx is associated with Organox Limited.

How many employees does OrganOx have?

As of Jun 30, 2026, the latest employee count at OrganOx is 234.

Is OrganOx a funded company?

OrganOx is a funded company, having raised a total of $45.4M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round.

How much is OrganOx worth?

The last known valuation of OrganOx was $***** as of Aug 23, 2025.

When was the latest funding round of OrganOx?

OrganOx's latest funding was a $***** Series D round on Feb 24, 2025, with participation from 13 investors.

What is the annual revenue of OrganOx?

Annual revenue of OrganOx is between £50M and £100M as on Apr 30, 2024

Where does OrganOx rank among its competitors?

OrganOx ranks 1st amongst 30 active competitors, of which 9 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Until Labs, which secured $58M in Sep, 2025.

Who are the top competitors of OrganOx?

OrganOx's top competitors include TransMedics, Paragonix Technologies and Bridge to Life. Among them, Until Labs secured the most recent funding round in September, 2025.

OrganOx - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is OrganOx an acquired company?

OrganOx got acquired by Terumo Medical on Aug 23, 2025.

OrganOx is an acquired company based in Oxford (United Kingdom), founded in 2008 by Peter Friend and Constantin Coussios. It operates as a Provider of a storage and transport system for harvested organs. OrganOx has raised $45.4M in funding from investors like BGF, Health Quest Capital and Lauxera Capital Partners, with last known valuation of $*****. The company has 30 active competitors, including 9 funded and 6 that have exited. Its top competitors include companies like TransMedics, Paragonix Technologies and Bridge to Life.

Company Details

Provider of a storage and transport system for harvested organs. The metra device has a rugged, robust design for ease of transport and safe storage when not in use. It has an extended battery life for transportation and a self regulating oxygen supply, removing the need to carry gas canister. The warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition.

Website: www.organox.com/
Social
Registered Address: The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT

Key Metrics

Founded Year

2008

Location

Oxford, United Kingdom

Stage

Acquired

Total Funding

$45.4M in 9 rounds

Latest Funding Round

Series D, Feb 24, 2025, $*****

Last Known Valuation

$***** as on Aug 23, 2025

Investors

BGF & 62 more

Ranked

1^st among 30 active competitors

Annual Revenue

£50M - £100M as on Apr 30, 2024

Employee Count

234 as on Jun 30, 2026

Similar Companies

TransMedics & 36 more

Exit Details

Acquired by Terumo Medical (Aug 23, 2025)

View OrganOx's full profile

OrganOx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Organox Limited CIN: 06557113 , United Kingdom, Active	Oct 05, 2016	£50M - £100M (As on Apr 30, 2024)	14 (As on Apr 30, 2018)

OrganOx got acquired by Terumo Medical on Aug 23, 2025 at an acquisition amount of $*****.

Click here to take a look at OrganOx's acquisition in detail

OrganOx has raised a total funding of $45.4M over 9 rounds. Its latest funding round was a Series D round on Feb 24, 2025 for $*****. 13 investors participated in its latest round. OrganOx has 27 institutional investors and 36 angel investors.

Here is the list of recent funding rounds of OrganOx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 24, 2025	2440309	Series D	7351567	7123886	3091227	8264517
Jul 17, 2023	3253782	Series D	8403437	3712393	2653583	8160560
Jan 08, 2020	2384898	Series D	1913848	8192456	BGF	1280214

Access funding benchmarks and valuations. Sign up today!

View details of OrganOx's funding rounds and investors

The founders of OrganOx are Peter Friend and Constantin Coussios. Craig Marshall is the CEO of OrganOx.

Here are the details of OrganOx's key team members:

Peter Friend: Co-Founder of OrganOx. They are also an angel investor in 2 startups and serve on the board of 1 company.
Constantin Coussios: Co-Founder of OrganOx and founder of 2 other companies, Dev Academy and OxSonics. They serve on the board of 1 company.
Craig Marshall: CEO of OrganOx. They are also an angel investor in 1 startup and serve on the board of 1 company.

OrganOx's Board of Directors

OrganOx's board has 8 active members. Craig Marshall, Peter Friend, Constantin Coussios and Oern Reidar Stuge are part of team and Graham Edwards, Timothy Read, Matthew Gerard Winston Frohn and Adam Workman are independent board members.

Here is the list of OrganOx's board of directors:

Name	Type	Representing	Status	Duration
Peter Friend	Team	-	Current	17y 7m
Constantin Coussios	Team	-	Current	17y 7m
judzoxs	Team	-	Current	5y 3m
lomnzrr	Team	-	Current	6y 2m
Graham Edwards	Independent board member	-	Current	6y 11m
xveodqe	Independent board member	-	Current	1y 3m
hlevewv	Independent board member	-	Current	3y 6m
ccnqwrl	Independent board member	-	Current	8y 9m
cgbi{mt	Independent board member	-	Past	2y 4m
thcooei	Independent board member	-	Past	4y 1m
okzxutl	Independent board member	-	Past	9y 2m
ivoewyj	Independent board member	-	Past	2y 9m
frofstd	Independent board member	-	Past	1y 6m
tvkypgd	Independent board member	-	Past	1y 5m
ppizdgu	Independent board member	-	Past	8y 8m

View details of OrganOx's Founder profiles and Board Members

OrganOx's employee count trend

OrganOx has 234 employees as of Jun 26. Here is OrganOx's employee count trend over the years:

Uncover OrganOx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OrganOx include TransMedics, Paragonix Technologies and Bridge to Life. Here is the list of Top 10 competitors of OrganOx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OrganOx 2008, Oxford (United Kingdom), Acquired	Provider of a storage and transport system for harvested organs	$45.4M	GT Healthcare Capital Partners, Terumo Medical ... & 61 others	76/100
2nd	TransMedics 1998, Andover (United States), Public	Developer of organ transplantation technology	$266M	Kleiner Perkins, Hercules Capital & 19 others	67/100
3rd	Paragonix Technologies 2010, Boston (United States), Acquired	Organ preservation technology improving transplant outcomes with digital tracking and clinical support	$25.1M	Signet Healthcare Partners, Massachusetts Life Sciences Center ... & 1 others	57/100
4th	Bridge to Life 2012, Columbia (United States), Series A	Provider of cold storage solutions for the preservation of organ transplants	$57M	Perceptive Advisors, SCRA	56/100
5th	Vascular Perfusion 2016, San Antonio (United States), Series D	Developer of a device for organ preservation	$152M	Capital Factory, Military Health	52/100
6th	XVIVO 1998, Gothenburg (Sweden), Public	Provider of organ preservation technologies and services. It offers machine perfusion technologies for kidneys, livers, and lungs, and a solution for cold static storage of lungs. The company also provides organ recovery and perfusion services. These technologies aim to increase organ utilization, extend preservation time, enable organ assessment, and improve transplant outcomes. A platform for sharing knowledge and experiences related to organ perfusion is also offered.	-	Europa	45/100
7th	Until Labs 2021, San Francisco (United States), Series A	Developer of reversible cryopreservation systems for human organs and tissues	$100M	Founders Fund, Lux Capital & 1 others	45/100
8th	ADVITOS 2005, Munich (Germany), Series B	Provider of multi-organ support systems	$23.8M	Credit Mutuel Equity, EIC Fund & 13 others	43/100
9th	Mitra Industries 1969, Delhi (India), Unfunded	Developer of noncardiac stents and blood bags	-	-	39/100
10th	Organ Recovery Systems 1998, Itasca (United States), Funding Raised	Organ preservation products and services improving transplant outcomes for patients	-	HHS	38/100